Deals
Organon's Third-Quarter Adjusted Earnings Slip To $0.94 A Share, And There Is No Earnings Call
Adjusted EBITDA fell to $502 million from $518 million as the pending Sun Pharmaceutical merger replaced the usual release and call.
Organon (OGN) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Deals
Adjusted EBITDA fell to $502 million from $518 million as the pending Sun Pharmaceutical merger replaced the usual release and call.
Earnings
Four established brands now carry the "Supply Constraints" label as full recovery of the supply chains is still ongoing, the company says.